1548 — Genscript Biotech Share News
0.000.00%
Last trade - 00:00- HK$76.05bn
- HK$72.43bn
- $959.53m
Brief: Genscript Biotech Announces Master Manufacturing And Supply Services Agreement With Novartis
Brief: GenScript Biotech Expands Collaboration With Roche
WuXi Biologics drops on concern over military ties; rivals dip
Brief: Genscript Biotech Says Exclusive Global Licensing Deal Between Legend And Novartis Closed
Brief: Genscript Biotech Announces Acquisition Of Shares By A Substantial Shareholder
Brief: Genscript Biotech And T-Maximum Biotech Form Strategic Alliance On cGMP sgRNA
HK-listed GenScript Biotech jumps most in near 9 months as unit generates sales
Brief: Genscript Biotech Says Carvykti® Generated Us$117 Mln In Net Trade Sales During Qtr
Brief: Genscript Biotech Sees HY Revenue From Life-Science Services & Products $197.1 Mln-$205.9 Mln
Brief: Genscript Expands Peptide And Oligonucleotide Production Facility In China
Brief: Genscript Biotech's Unit Legend Biotech Entered Deal With Investment Adviser To Sell ADSs
Brief: Genscript Biotech Announces Deemed Disposal Of Equity Interest In Legend Biotech
Brief: Genscript Biotech Says Legend Biotech Filed A Form 6-K With U.S. SEC
China's Genscript Biotech hits 5-month low after posting yearly loss
Brief: Genscript Biotech Posts FY Loss Of $428.0 Million
Brief: Genscript Biotech Says Legend Biotech Regained Compliance With Nasdaq Listing Rule
Hillhouse-backed GenScript ProBio to raise $224 mln from Legend Capital, others
Brief: Genscript Biotech Agrees To Issue And Sell 320 Million Series C Preferred Shares
Brief: GenScript Partners With Allozymes To Accelerate Protein Discovery, Target Identification